Viewing StudyNCT00474188



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00474188
Status: TERMINATED
Last Update Posted: 2009-09-02
First Post: 2007-05-14

Brief Title: A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Celgene Corporation
Organization: Celgene

Conditions & Keywords Data

Conditions:
Name
Diffuse Large B-cell Lymphoma
Keywords:
Name View
Progression-free survival and safety View
Celgene View
Revlimid View
Lenalidomide View
Diffuse Large B-cell lymphoma View
Non-Hodgkins lymphoma View
CC-5013 View
Response Rate View
Tumor Control Rate View
Duration of Response View
Time to Progression View